← Back
Data updated: Mar 10, 2026
KASHIV BIOSCIENCES LLC
OncologyImmunology
KASHIV BIOSCIENCES LLC is a biotechnology company focused on Oncology, Immunology.
2022
Since
2
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 88%
1 drugs Phase 1: 1
Immunology 13%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...